| scholarly article | Q13442814 |
| P50 | author | Robert Tampé | Q37382636 |
| Peter M van Endert | Q40529899 | ||
| Hermann-Georg Holzhütter | Q47262394 | ||
| Sascha Bulik | Q86591672 | ||
| P2093 | author name string | Björn Peters | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1741-1749 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors | |
| P478 | volume | 171 |
| Q41602064 | A Computational Approach for Designing a Universal Epitope-Based Peptide Vaccine Against Nipah Virus |
| Q33247448 | A community resource benchmarking predictions of peptide binding to MHC-I molecules |
| Q57794299 | A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins |
| Q42174757 | A computational assay to design an epitope-based Peptide vaccine against saint louis encephalitis virus. |
| Q51965134 | A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules. |
| Q33342843 | A detailed analysis of the murine TAP transporter substrate specificity |
| Q34815702 | A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy. |
| Q21092515 | A peptide filtering relation quantifies MHC class I peptide optimization |
| Q35575957 | Ab and T cell epitopes of influenza A virus, knowledge and opportunities |
| Q35645154 | Accurate prediction of immunogenic T-cell epitopes from epitope sequences using the genetic algorithm-based ensemble learning |
| Q36431881 | An analysis of the epitope knowledge related to Mycobacteria |
| Q34484256 | An assessment on epitope prediction methods for protozoa genomes. |
| Q51969975 | An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. |
| Q36483367 | An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort |
| Q37356355 | An introduction to epitope prediction methods and software |
| Q43105249 | Analysis and prediction of affinity of TAP binding peptides using cascade SVM. |
| Q60947009 | Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis |
| Q34586710 | Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource |
| Q36129290 | Assessment of cancer and virus antigens for cross-reactivity in human tissues |
| Q36153773 | Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California. |
| Q34055255 | Bacteria modulate the CD8+ T cell epitope repertoire of host cytosol-exposed proteins to manipulate the host immune response |
| Q92963159 | Best practices for bioinformatic characterization of neoantigens for clinical utility |
| Q38262688 | Bioinformatics for cancer immunotherapy target discovery |
| Q44396424 | Bioinformatics identification of antigenic peptide: predicting the specificity of major MHC class I and II pathway players |
| Q33807043 | Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation |
| Q36266433 | Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation. |
| Q34201227 | Computer aided prediction and identification of potential epitopes in the receptor binding domain (RBD) of spike (S) glycoprotein of MERS-CoV. |
| Q38554524 | Computer-aided design of T-cell epitope-based vaccines: addressing population coverage |
| Q50421456 | Cross-modality deep learning-based prediction of TAP binding and naturally processed peptide. |
| Q55342452 | Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B. |
| Q90064824 | DeepLigand: accurate prediction of MHC class I ligands using peptide embedding |
| Q34059416 | Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1 |
| Q30932156 | Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior |
| Q41754327 | Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach |
| Q52696613 | Design of peptide-based epitope vaccine and further binding site scrutiny led to groundswell in drug discovery against Lassa virus. |
| Q92239054 | Designing a multi-epitopic vaccine against the enterotoxigenic Bacteroides fragilis based on immunoinformatics approach |
| Q51991472 | Discriminating self from nonself with short peptides from large proteomes. |
| Q47782025 | Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes |
| Q35100809 | Emerging vaccine informatics |
| Q33236277 | EpiJen: a server for multistep T cell epitope prediction |
| Q39141825 | Estimate of within population incremental selection through branch imbalance in lineage trees. |
| Q41491347 | Expitope: a web server for epitope expression |
| Q38868912 | Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection. |
| Q24815448 | Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method |
| Q52906767 | Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes. |
| Q33299493 | HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. |
| Q28473871 | HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses |
| Q33628719 | High throughput T epitope mapping and vaccine development |
| Q46832079 | Host genotype and time dependent antigen presentation of viral peptides: predictions from theory. |
| Q41839973 | Human self-protein CD8+ T-cell epitopes are both positively and negatively selected |
| Q41725375 | Identification and validation of T-cell epitopes in outer membrane protein (OMP) of Salmonella typhi |
| Q36870592 | Identification of T-cell epitopes for cancer immunotherapy |
| Q62050532 | Identifying neoantigens for use in immunotherapy |
| Q35076926 | Immune-induced evolutionary selection focused on a single reading frame in overlapping hepatitis B virus proteins |
| Q30250980 | ImmunoNodes - graphical development of complex immunoinformatics workflows |
| Q38318484 | Immunogenic peptide discovery in cancer genomes. |
| Q58580637 | Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus |
| Q31162563 | Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies |
| Q21145682 | Immunoinformatics comes of age |
| Q33753964 | In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein |
| Q64360040 | In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice |
| Q64100250 | In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
| Q36083324 | In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy |
| Q91404901 | Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model |
| Q86757309 | Induction of an antitumor response using dendritic cells transfected with DNA constructs encoding the HLA-A*02:01-restricted epitopes of tumor-associated antigens in culture of mononuclear cells of breast cancer patients |
| Q37748492 | Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses |
| Q34429970 | Integrated modeling of the major events in the MHC class I antigen processing pathway |
| Q34055991 | Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials |
| Q33304572 | Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction |
| Q64279278 | Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides |
| Q36266437 | MHC class I alleles and their exploration of the antigen-processing machinery |
| Q30388353 | MHC class II epitope predictive algorithms. |
| Q91671018 | Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors |
| Q37762296 | Major histocompatibility complex class I binding predictions as a tool in epitope discovery. |
| Q40171180 | Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis. |
| Q48372980 | Modeling the adaptive immune system: predictions and simulations. |
| Q33873269 | NetCTLpan: pan-specific MHC class I pathway epitope predictions |
| Q51083423 | NetTepi: an integrated method for the prediction of T cell epitopes. |
| Q38168900 | Novel approaches in polyepitope T-cell vaccine development against HIV-1. |
| Q39166782 | Optimal viral immune surveillance evasion strategies |
| Q34612155 | POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties |
| Q34074865 | POPISK: T-cell reactivity prediction using support vector machines and string kernels |
| Q34882801 | PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing |
| Q92343941 | Peptide-Based Subunit Vaccine Design of T- and B-Cells Multi-Epitopes against Zika Virus Using Immunoinformatics Approaches |
| Q93039767 | Personalized Neo-Epitope Vaccines for Cancer Treatment |
| Q42098721 | Phase-dependent immune evasion of herpesviruses |
| Q35012688 | PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens |
| Q58129532 | Predicting T cell recognition of MHC class I restricted neoepitopes |
| Q33608371 | Predicting alloreactivity in transplantation |
| Q36394575 | Prediction and in vitro verification of potential CTL epitopes conserved among PRRSV-2 strains |
| Q33289831 | Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method |
| Q37806810 | Prediction of epitopes using neural network based methods |
| Q98771735 | Progress in Neoantigen Targeted Cancer Immunotherapies |
| Q35034097 | Properties of MHC class I presented peptides that enhance immunogenicity |
| Q34276972 | Proteome sampling by the HLA class I antigen processing pathway |
| Q36999665 | Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance. |
| Q41726495 | Role of peptide processing predictions in T cell epitope identification: contribution of different prediction programs. |
| Q37898727 | Running the gauntlet: from peptide generation to antigen presentation by MHC class I. |
| Q34399680 | Short communication: HIV-1 Nef protein carries multiple epitopes suitable for induction of cellular immunity for an HIV vaccine in Africa |
| Q34669311 | Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development |
| Q33927361 | Single residue within the antigen translocation complex TAP controls the epitope repertoire by stabilizing a receptive conformation |
| Q59812984 | Specific MHC-I Peptides Are Induced Using PROTACs |
| Q34312500 | State of the art and challenges in sequence based T-cell epitope prediction |
| Q59813602 | Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach |
| Q58587953 | Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes |
| Q56535000 | Systems Immunology: Learning the Rules of the Immune System |
| Q40171653 | T-cell epitopes predicted from the Nucleocapsid protein of Sin Nombre virus restricted to 30 HLA alleles common to the North American population |
| Q34160255 | TAP Hunter: a SVM-based system for predicting TAP ligands using local description of amino acid sequence |
| Q39149196 | Targeting neoantigens to augment antitumour immunity |
| Q30400430 | The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design |
| Q38753386 | The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer |
| Q33490243 | The distribution of CTL epitopes in HIV-1 appears to be random, and similar to that of other proteomes |
| Q36927645 | The immunoinformatics of cancer immunotherapy |
| Q58705894 | The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response |
| Q56879701 | The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage |
| Q33791476 | The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. |
| Q37939072 | Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools. |
| Q38088325 | Towards in silico design of epitope-based vaccines |
| Q36932732 | Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge |
| Q28082704 | Tumor neoantigens: building a framework for personalized cancer immunotherapy |
| Q40857597 | Two highly similar LAEDDTNAQKT and LTDKIGTEI epitopes in G glycoprotein may be useful for effective epitope based vaccine design against pathogenic Henipavirus |
| Q30398403 | Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT. |
| Q41673794 | Viral CD8 T cell epitope nucleotide composition shows evidence of short- and long-term evolutionary strategies |
| Q37206378 | Viruses selectively mutate their CD8+ T-cell epitopes--a large-scale immunomic analysis |
| Q33916280 | Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response |
Search more.